TY - JOUR
T1 - Direct demonstration of involvement of the adaptor protein ShcA in the regulation of Ca 2+-induced platelet aggregation
AU - Higashi, Tomohito
AU - Yoshioka, Akira
AU - Shirakawa, Ryutaro
AU - Tabuchi, Arata
AU - Nishioka, Hiroaki
AU - Kita, Toru
AU - Horiuchi, Hisanori
N1 - Funding Information:
We are also grateful to the Kyoto Red Cross Blood Center for providing platelet pellet and to T. Matsubara for excellent technical assistance. This work was supported by Research Grants from Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 16-1244 to R.S., 12CE2006 and 16209031 to T.K., and No. 15590740 and 15081206 to H.H.,), Health and Labour Sciences Research Grants from Research Grants from Ministry of Health Labour and Welfare, Japan (Comprehensive Research on Aging and Health (H14-Tyouju-012) to T.K. and H.H.), and partially by grants from Takeda Science Foundation, Suzuken Memorial Foundation, Study Group of Molecular Cardiology and Novartis Foundation for Gerontological Research to H.H.
PY - 2004/9/17
Y1 - 2004/9/17
N2 - Platelet aggregation is mediated by conformational change of integrin α IIbβ 3. Tyrosine-phosphorylation of cytoplasmic domain of β 3 upon platelet activation has been demonstrated to play a critical role in this process. Recently, the adaptor protein ShcA has been shown to bind to the tyrosine-phosphorylated β 3, while it remains open whether ShcA plays any role in platelet aggregation. Here, we show that ShcA bound to tyrosine-phosphorylated β 3-tail peptide through its phosphotyrosine-binding domain in vitro. Then, we examined the involvement of ShcA in platelet aggregation by a previously established in vitro assay using platelets permeabilized with streptolysin-O, where exogenous addition of platelet cytosol is required for reconstitution of the Ca 2+-induced aggregation. When ShcA was specifically depleted with anti-ShcA antibody from the cytosol, this ShcA-depleted cytosol lost the aggregation-supporting activity, which was rescued by addition of purified recombinant ShcA. Thus, ShcA is essential for the Ca 2+-induced platelet aggregation.
AB - Platelet aggregation is mediated by conformational change of integrin α IIbβ 3. Tyrosine-phosphorylation of cytoplasmic domain of β 3 upon platelet activation has been demonstrated to play a critical role in this process. Recently, the adaptor protein ShcA has been shown to bind to the tyrosine-phosphorylated β 3, while it remains open whether ShcA plays any role in platelet aggregation. Here, we show that ShcA bound to tyrosine-phosphorylated β 3-tail peptide through its phosphotyrosine-binding domain in vitro. Then, we examined the involvement of ShcA in platelet aggregation by a previously established in vitro assay using platelets permeabilized with streptolysin-O, where exogenous addition of platelet cytosol is required for reconstitution of the Ca 2+-induced aggregation. When ShcA was specifically depleted with anti-ShcA antibody from the cytosol, this ShcA-depleted cytosol lost the aggregation-supporting activity, which was rescued by addition of purified recombinant ShcA. Thus, ShcA is essential for the Ca 2+-induced platelet aggregation.
KW - Aggregation
KW - Integrin
KW - Phosphotyrosine-binding domain
KW - Platelet
KW - ShcA
KW - Streptolysin-O
UR - http://www.scopus.com/inward/record.url?scp=6044221531&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=6044221531&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2004.07.177
DO - 10.1016/j.bbrc.2004.07.177
M3 - Article
C2 - 15325286
AN - SCOPUS:6044221531
SN - 0006-291X
VL - 322
SP - 700
EP - 704
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -